COVID-19, anemia, arthralgia, injection site reaction, increased alanine aminotransferase, and abdominal pain (for UC).COVID-19, headache, upper respiratory tract infection, injection site reaction, diarrhea, increased blood creatine phosphokinase, arthralgia, increased alanine aminotransferase, hypertension, urinary tract infection, neutropenia, dizziness, and leukopenia (for CD). This evidence concerns the gene GPT and Decreased total leukocyte count.